More precisely, we detected high VEGF-C levels in patients with solely retroperitoneal spread while tumors of patients with intraperitoneal tumor growth, regardless of lymph node status, expressed lower VEGF-C levels (Kuerti et al. 2017). Here, VEGFC is linked to neoplasm.